Gene · 51548
Papers4,574
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,574
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of POPs-induced SIRT6 alteration on intestinal mucosal barrier function: A comprehensive review. | Ecotoxicol Environ Saf | 2025 | 39805197 | PubTator, text mining | PubMed |
| Corrigendum to "SIRT6 knockdown alleviates keratinocyte hyperproliferation and inflammation in psoriasis via modulating acetylation of FOXO1" [Int. Immunopharmacol. 146 (2024) 113932]. | Int Immunopharmacol | 2025 | 39799026 | PubTator, text mining | PubMed |
| SIRT6 regulates the HIPK2/P53 pathway to reduce oxidative stress and apoptosis to attenuate vancomycin-induced nephrotoxicity. | Mutat Res | 2025 | 39764940 | PubTator, text mining | PubMed |
| Phylogenetic analysis and detection of positive selection in the SIRT gene family across vertebrates. | Sci Rep | 2025 | 39757258 | PubTator, text mining | PubMed |
| Sirt6, Deubiquitinated and Stabilised by USP9X, Takes Essential Actions on the Pathogenesis of Experimental Autoimmune Myasthenia Gravis by Regulating CD4+ T Cells. | Clin Exp Pharmacol Physiol | 2025 | 39756480 | PubTator, text mining | PubMed |
| Sirt6 regulates the Notch signaling pathway and mediates autophagy and regulates podocyte damage in diabetic nephropathy. | J Bioenerg Biomembr | 2025 | 39754634 | PubTator, text mining | PubMed |
| SIRT6 promotes angiogenesis by enhancing VEGFA secretion via demyristoylation in endothelial cell. | J Mol Cell Cardiol | 2025 | 39753390 | PubTator, text mining | PubMed |
| EFFECT AND REGULATORY MECHANISM OF SIRT6 ON POSTCARDIAC ARREST BRAIN INJURY IN RATS. | Shock | 2025 | 39749948 | PubTator, text mining | PubMed |
| YAP K236 acetylation facilitates its nucleic export and deprived the protection against cardiac hypertrophy in mice. | Pharmacol Res | 2025 | 39746498 | PubTator, text mining | PubMed |
| SIRT6 knockdown alleviates keratinocyte hyperproliferation and inflammation in psoriasis via modulating acetylation of FOXO1. | Int Immunopharmacol | 2025 | 39733643 | PubTator, text mining | PubMed |
| [Corrigendum] Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1‑5 and increased expression of SIRT 6 and 7. | Int J Mol Med | 2025 | 39704217 | PubTator, text mining | PubMed |
| Transcriptomic analysis and epigenetic regulators in human oocytes at different stages of oocyte meiotic maturation. | Dev Biol | 2025 | 39681207 | PubTator, text mining | PubMed |
| Targeting PPARα/γ by icariside II to rescue GalN/LPS-induced acute liver injury in mice: Involvement of SIRT6/NF-κB signaling pathway. | Phytomedicine | 2025 | 39674121 | PubTator, text mining | PubMed |
| SIRT6 mitigates oxidative stress and RSL3-induced ferroptosis in HTR-8/SVneo cells. | Tissue Cell | 2025 | 39642638 | PubTator, text mining | PubMed |
| Energy Stress-Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma. | Cancer Res | 2025 | 39636740 | PubTator, text mining | PubMed |
| SGK1-Mediated Vascular Smooth Muscle Cell Phenotypic Transformation Promotes Thoracic Aortic Dissection Progression. | Arterioscler Thromb Vasc Biol | 2025 | 39633576 | PubTator, text mining | PubMed |
| Caloric restriction mimetics: Pinostilbene versus resveratrol regarding SIRT1 and SIRT6 interaction. | Adv Med Sci | 2025 | 39617052 | PubTator, text mining | PubMed |
| The protein composition of human adenovirus replication compartments. | mBio | 2025 | 39611842 | PubTator, text mining | PubMed |
Phase 1, Single-Center, Double-Blind, Randomized, Placebo-Controlled Studies of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of the Sirtuin 6 Activator SP-624 in Healthy Adults. | Clin Pharmacol Drug Dev | 2025 | 39587867 | PubTator, text mining | PubMed |
| [Retracted] SIRT6 promotes ferroptosis and attenuates glycolysis in pancreatic cancer through regulation of the NF‑κB pathway. | Exp Ther Med | 2025 | 39534285 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51548/papers?page=15